Clinical Trials · NCT02417103
Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid
- Phase
- Phase 3
- Recruitment status
- Terminated
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Enrollment
- 2
- Start date
- Dec 2011
- Locations
- 1 site, Germany
- Primary endpoint
- weight reduction